EKF Diagnostics Holdings plc (LON:EKF – Get Rating) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 38.17 ($0.45) and traded as high as GBX 44.32 ($0.52). EKF Diagnostics shares last traded at GBX 42.60 ($0.50), with a volume of 81,906 shares trading hands.
EKF Diagnostics Price Performance
The firm has a fifty day moving average price of GBX 41.87 and a two-hundred day moving average price of GBX 38.17. The stock has a market capitalization of £193.80 million and a P/E ratio of 2,130.00. The company has a debt-to-equity ratio of 2.21, a quick ratio of 1.77 and a current ratio of 2.50.
EKF Diagnostics Increases Dividend
The company also recently declared a dividend, which will be paid on Thursday, December 1st. Stockholders of record on Thursday, November 3rd will be issued a dividend of GBX 1.20 ($0.01) per share. This represents a dividend yield of 2.35%. This is a boost from EKF Diagnostics’s previous dividend of $1.10. The ex-dividend date is Thursday, November 3rd. EKF Diagnostics’s dividend payout ratio is presently 55.00%.
About EKF Diagnostics
EKF Diagnostics Holdings plc designs, develops, manufactures, and sells diagnostic instruments, reagents, and other ancillary products in Europe, the Middle East, the Americas, Asia, Africa, and internationally. It offers DiaSpect Tm hand-held hemoglobin analyzer; DiaSpect Hemoglobin T analyzer; Hemo Control, a hemoglobin analyzer that provides quantitative and lab quality hemoglobin results; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples.
- Power Integrations Stock Can Power Your Portfolio
- Don’t Chase Walmart Higher, Wait For Extra Low Prices
- Home Depot Results (and Institutions) Are A Catalyst For Lowe’s?
- Three Penny Stocks Making Big Moves In November
- Agilent Remains In Buy Range Ahead Of Next Week’s Q4 Report
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.